Join Us! Pharma Pricing and Benefit Management Symposium – April 12th
March 29, 2018
We are pleased to be hosting the Nephron Research Pharma Pricing and Benefit Management Symposium, in NYC on Thursday, April 12th, 2018. The Symposium will bring together a diverse set of Biopharma, PBM and Payor leaders and innovators for a series of panels. Here are three reasons healthcare services AND therapeutics investors shouldn’t miss this year’s event:
- The relationship between gross and net pharma expenditures is changing: IQVIA’s Michael Kleinrock, the foremost expert on pharma pricing mechanics, will provide the latest outlook on brand and generic pricing trends.
- Biopharma, PBM & Payor views on price and value are converging: A rare chance to see leadership from PhRMA, BIO, PCMA and AHIP sit down at the same table to discuss pricing, value based relationships and potential areas of regulatory/legislative action.
- With Payor/PBM consolidation, the opportunity for managing across benefits is expanding: While others point to opportunities for med/Rx synchronization, Prime and Magellan are already demonstrating benefits. We present Prime CMO Jon Gavras, Magellan Rx CEO Mostafa Kamal and innovative Payor perspectives from Horizon BCBS and UPMC.
Link to conference details and full agenda: https://bit.ly/2GoCvuI
If you are interested in joining us, please email: info@nephronresearch.com